New York, NY · Founded 2022 · Privately Held (backing)
Provider of molecular diagnostic kits intended to enhance the accuracy and timeliness of disease detection. Reme-D is based in New York, NY and was founded in 2022. Its last reported valuation was $330,000 in May 2024. It has raised $520,000.
Last reported valuation
$330K
Oct 2026
Priced at
—
Total raised
$520K
Last round
—
Team — not yet on record
No current team members for Reme-D are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Reme-D with a free account
·Watch Reme-D: the Monday email on marks, rounds and moves
